Enhanced Community Pharmacy service

{
  "awards": [
    {
      "id": "021919-2026-1",
      "relatedLots": [
        "1"
      ],
      "status": "active",
      "suppliers": [
        {
          "id": "GB-COH-09774179",
          "name": "NUP S Corporation Ltd T/A Omcare Late Night Pharmacy"
        }
      ]
    }
  ],
  "bids": {
    "statistics": [
      {
        "id": "1",
        "measure": "bids",
        "relatedLot": "1",
        "value": 1
      }
    ]
  },
  "buyer": {
    "id": "GB-NHS-QK1000",
    "name": "NHS Leicester, Leicestershire and Rutland ICB"
  },
  "contracts": [
    {
      "awardID": "021919-2026-1",
      "dateSigned": "2026-03-03T00:00:00Z",
      "id": "021919-2026-1",
      "status": "active",
      "value": {
        "amount": 480000,
        "currency": "GBP"
      }
    }
  ],
  "date": "2026-03-11T15:52:39Z",
  "description": "This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. \nThe standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by 23rd March 2026. \nThis contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.\n- Details of the award decision-makers: NHS LNR ICB cluster Committees Meeting in Common for Finance and Contracting 03 March 2026\n- How conflicts or potential conflicts of interest of individuals making the decision were managed: None were declared\n- Explanation of the relative importance of the PSR\u0027s key criteria:\nRelative importance of the key criteria:\n1.\tQuality and innovation\n During the pilot and the existing contracting period all quality outcomes for service delivery with the provider were assured.  Acceptable processes are in place to recognise and report patient safety incidents. Good processes in place to mitigate risks, their QS RAG rating was agreed as Good. \n2.\tValue\nThe provider has demonstrated how the service has delivered measurable value for money through reduced duplication, efficient resource utilisation, and the avoidance of unnecessary hospital admissions or escalation of care. \n3.\tIntegration, collaboration and service sustainability\nThe service is delivered in an integrated way, and the provider has engaged fully with all system stakeholders through the Improving Access to Anticipatory Medications workgroup. The service is sustainable based on current activity levels which are as predicted and are on average 14 per week.\n4.\tImproving access, reducing health inequalities and facilitating choice\nOne of the primary objectives of the pilot was to improve access to medications in the community and the interim evaluation clearly shows that this has been achieved and is a marked improvement on the previous model. \nThe service has ensured a reduction in inequalities, as patients receive medications regardless of their access to transport or ability to travel.\nThe service facilitates choice for patients in relation to their preferred place of death / care, ensuring that pain and other symptoms can be managed at home in a timely and manageable way.\n5.\tSocial value\nPrior to the pilot, carers and family members were required to locate the medications prescribed which often involved visiting 4-5 separate pharmacies at a time when their loved one was in their last hours. The social value of enabling families to be at the bedside of their loved one is immeasurable.",
  "id": "021919-2026",
  "initiationType": "tender",
  "language": "en",
  "ocid": "ocds-h6vhtk-066789",
  "parties": [
    {
      "address": {
        "countryName": "United Kingdom",
        "locality": "Leicester",
        "postalCode": "LE3 8TB",
        "region": "UKF",
        "streetAddress": "Room G30, Pen Lloyd Building, County Hall, Glenfield"
      },
      "contactPoint": {
        "email": "llricb-llr.contracting@nhs.net"
      },
      "details": {
        "buyerProfile": "https://health-family.force.com/s/Welcome",
        "classifications": [
          {
            "description": "Body governed by public law",
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE"
          },
          {
            "description": "Health",
            "id": "07",
            "scheme": "COFOG"
          }
        ],
        "url": "https://leicesterleicestershireandrutland.icb.nhs.uk/"
      },
      "id": "GB-NHS-QK1000",
      "identifier": {
        "id": "QK1000",
        "legalName": "NHS Leicester, Leicestershire and Rutland ICB",
        "scheme": "GB-NHS"
      },
      "name": "NHS Leicester, Leicestershire and Rutland ICB",
      "roles": [
        "buyer"
      ]
    },
    {
      "address": {
        "countryName": "United Kingdom",
        "locality": "Leicester",
        "postalCode": "LE4 5AU",
        "region": "UKF21"
      },
      "details": {
        "scale": "sme"
      },
      "id": "GB-COH-09774179",
      "identifier": {
        "id": "09774179",
        "legalName": "NUP S Corporation Ltd T/A Omcare Late Night Pharmacy",
        "scheme": "GB-COH"
      },
      "name": "NUP S Corporation Ltd T/A Omcare Late Night Pharmacy",
      "roles": [
        "supplier"
      ]
    },
    {
      "address": {
        "countryName": "United Kingdom",
        "locality": "Leicester"
      },
      "id": "GB-FTS-138074",
      "identifier": {
        "legalName": "NHS Leicester, Leicestershire and Rutland ICB"
      },
      "name": "NHS Leicester, Leicestershire and Rutland ICB",
      "roles": [
        "reviewBody"
      ]
    }
  ],
  "tag": [
    "award",
    "contract"
  ],
  "tender": {
    "classification": {
      "description": "Health and social work services",
      "id": "85000000",
      "scheme": "CPV"
    },
    "description": "The service is to deliver end-of-life medicines and urgent\ncommunity (palliative care drugs) in Leicester, Leicestershire and Rutland.",
    "id": "ocds-h6vhtk-066789",
    "items": [
      {
        "deliveryAddresses": [
          {
            "region": "UKF21"
          },
          {
            "region": "UKF22"
          }
        ],
        "id": "1",
        "relatedLot": "1"
      }
    ],
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "lots": [
      {
        "awardCriteria": {
          "criteria": [
            {
              "description": "100",
              "name": "The existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard",
              "type": "cost"
            }
          ]
        },
        "description": "This notice is for a Direct Award C PSR process to commence from the 1 April 2026 for 24 months with possibility of extension of up to an additional 12 months, bringing the lifetime value of the contract to the value of c. \u00a3480,000.  Under the test for considerable change this is within the permitted criteria (not exceeding \u00a3500,000).\nThe ICB is intending to award a contract to an existing provider following direct award process C, where the existing provider is satisfying the existing contract and will likely satisfy the proposed new contract, and the contract is not changing considerably, and the test for considerable change is not met.\nThe approximate lifetime value of the contract is \u00a3480,000\nThe dates between which the services are intended to be provided are: 01/04/2026 to 31/03/2028.\nAims and objectives of the service:\n\u2022 The aim of this enhanced service is to provide service users and clinicians with prompt access to a range of palliative care and specialist medications on an urgent basis.\n\u2022 Improving access to End of Life (EoL) medication is also expected to reduce pressure on secondary care providers and facilitate admission avoidance. If medication needs can be met\nin a timely manner, more patients will be able to stay at home. Additional information: Possibility of extension of up to an additional 12 months, bringing the lifetime value of the contract to the value of c. \u00a3480,000",
        "hasOptions": false,
        "id": "1",
        "status": "cancelled"
      }
    ],
    "mainProcurementCategory": "services",
    "procurementMethod": "limited",
    "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
    "procurementMethodRationale": "This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. \nThe publication of this notice marks the start of the standstill period, which begins the day after this notice is published.\nRepresentations by providers must be made to the relevant authority b ymidnight of the 23rd March 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.",
    "procurementMethodRationaleClassifications": [
      {
        "description": "The procurement falls outside the scope of application of the directive",
        "id": "D_OUTSIDE_SCOPE",
        "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL"
      }
    ],
    "status": "complete",
    "title": "Enhanced Community Pharmacy service"
  }
}